Xponance’s NEVRO CORP. NVRO Stock Holding History

Xponance’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,054	Closed	-$340K	–	1242
2021 Q2	$340K	Buy	+2,054	New	+$321K	0.01%	1040

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Xponance's NVRO Position: Q3 2021 in Review

Xponance sold out of NEVRO CORP. (NVRO) in Q3 2021, closing a stake of 2,054 shares — an estimated $340K sold.

Xponance first reported a position in NVRO in Q2 2021 and held it in 1 quarter. The position peaked at $340K in Q2 2021. 194 funds tracked by Wall St. Rank hold NVRO as of Q3 2021.

Xponance reported no remaining NEVRO CORP. position as of Q3 2021 after selling out during the quarter.
Xponance sold 2,054 NEVRO CORP. shares in Q3 2021, an estimated $340K.
Xponance first reported a position in NEVRO CORP. in Q2 2021 and held it in 1 quarter.
Xponance's NEVRO CORP. position peaked at $340K in Q2 2021.
194 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2021.

Based on Xponance's 13F filing for Q3 2021, filed 5 Nov 2021.